Last reviewed · How we verify
NCT05245149
Image Quality and Radiation Dose Associated With Cardiac Scans in Modern CT Scanners
trial testing Cardiac CTA on a photon-counting detector CT (PCD-CT) in Coronary Artery Disease in 200 participants. Status unknown.
30 August 2023
Quick facts
| Lead sponsor | University Hospital Augsburg |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 20 February 2022 |
| Primary completion | 30 August 2023 |
| Estimated completion | 30 August 2024 |
Drugs / interventions tested
- Cardiac CTA on a photon-counting detector CT (PCD-CT)
- Cardiac CTA on a regular CT with Energy-Integrating Detector (EID-CT)
Conditions studied
- Coronary Artery Disease — all drugs for Coronary Artery Disease →
Sponsor
University Hospital Augsburg
Who can join
18 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective of this study is to evaluate the dose efficiency of coronary CT angiography (CTA) using a photon counting detector CT (PCD-CT) with the dose efficiency of coronary CT angiography of prior CT generations. 100 patients with a clinical indication for coronary CT angiography will be prospectively enrolled and undergo coronary CTA on a PCD-CT. For comparison, a matched retrospective cohort of 100 patients will be created who had undergone on a prior scanner generation (retrospective cohort).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05245149
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronary Artery Disease
Currently open trials in the same condition.
- NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
- NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
- NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting
Other University Hospital Augsburg trials
Trials by the same sponsor.
- NCT07482956 — BCC-One-Stop-Study · NA · not yet recruiting
- NCT05899387 — Seroma of the Mammary Gland · NA · recruiting
- NCT06294405 — Intraocular Lens Implant Registry Study · recruiting
- NCT06365138 — Analysis of Individual Activity at the Time of Aortic Rupture in Patients With Abdominal Aortic Aneurysms · recruiting
- NCT05846321 — Registry for Vascular Trauma and Follow-up Examinations · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05245149 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Augsburg
- Last refreshed: 17 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05245149.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing